<h1>Annex A: Avilamycin</h1>
<h2>A.1 Introduction</h2>
<p>A.6.1 Salmonella</p>
<h2>A.8 Toxicological aspects A.9 Environmental effects A.10 Summary comments</h2>
<p>References</p>
<h2>Annex B: Bacitracin</h2>
<h2>B.1 Introduction</h2>
<p>B.3.1 Prospective studies</p>
<p>B.3.2 Point-prevalence studies</p>
<h2>B.8 Toxicological aspects</h2>
<p>B.8.2 Allergy</p>
<h2>B.9 Environmental effects B.10 Summary comments</h2>
<p>References 107-114. 713-723. *OURNAL OF "ACTERIOLOGY 3784-3789. #LINICAL )NFECTIOUS $ISEASES 1520. 374. 832-837. .UTRITION 100-110. 647. *ONSON ' AND *ACOBSSON 3 %  , 1973. Foderantibiotikas inverkan på kalvdödlighet. 3VENSK 6ETERIN¤RTIDNING 17-22. 62-70. 256-261. 976. 1UINLAN ' * AND 'UTTERIDGE *  - , 1989. Bacitracin and a bacitracin-zinc complex 150.</p>
<p>Copenhagen. p. 178.</p>
<h2>Annex C: Flavomycin</h2>
<h2>C.1 Introduction</h2>
<p>C.3.1 Prospective studies</p>
<p>C.3.2 Point-prevalence studies</p>
<p>C.7.1 Salmonella</p>
<h2>C.8 Toxicological aspects</h2>
<p>C.8.1 Allergy</p>
<h2>C.9 Environmental effects C.10 Summary comments</h2>
<p>References 44:832-837. 45:2336-2341. 63:199-225.</p>
<p>Poultry Science. 63:2036-2042.</p>
<h2>D.1 Introduction</h2>
<p>Experimental studies</p>
<p>Cohort studies</p>
<p>Point prevalence studies</p>
<p>Co-transfer of genes additives.</p>
<p>D.7.1 Salmonella</p>
<h2>D.8 Toxicological aspects D.9 Environmental effects D.10 Summary comments</h2>
<p>References 107-114. 117-127. #ONTACT $ERMATITIS 115. %PIDEMIOLOGY AND )NFECTION 239-252. 832-837. 714. 'REKO #  , 1996. Inventering av resistens mot antibakteriella medel hos enterokocker från kyckling (rapport). National Veterinary Institute, Uppsala.</p>
<p>Butterworths,Nottingham. pp. 369-384. 6ETERINARY 2ECORD 495-500.</p>
<p>Serumlaboratorium, Copenhagen. 272. &%-3 -ICROBIOLOGY LETTERS 165-172. 2016-2018. 359-363. *OURNAL OF (YGIENE 217-231. 150.</p>
<p>VAN DEN "OGAARD ! ,ONDON . $RIESSEN # AND 3TOBBERINGH % , 1996. Prevalence 1136. 179-184. 114.</p>
<h2>E.1 Introduction</h2>
<p>E.1.2 Streptogramins (virginiamycin)</p>
<p>E.3.1 Prospective studies</p>
<p>Experimental studies</p>
<p>Field studies</p>
<p>E.3.2 Retrospective studies</p>
<p>E.3.3 Point-prevalence studies</p>
<p>Enterococci</p>
<p>Staphylococci</p>
<p>Campylobacter</p>
<p>Serpulina</p>
<h2>E.4.1 Target modification</h2>
<p>Enterococci and streptococci</p>
<p>Staphylococci</p>
<p>Clostridia</p>
<p>E.4.2 Enzymatic inactivation</p>
<p>E.4.3 Active efflux</p>
<p>E.7.1 Salmonella found.</p>
<p>E.7.3 Other effects</p>
<h2>E.8 Toxicological aspects</h2>
<p>E.8.1 Residues</p>
<p>E.8.2 Allergy</p>
<h2>E.9 Environmental effects E.10 Summary comments</h2>
<p>References !POTEKSBOLAGET  1996.  3VENSK ,¤KEMEDELSSTATISTIK Apoteksbolaget AB, Stockholm. pp.  pp.141-145. 0066-4804. 1739-1745. 832-837. 'REKO #  , 1996. Inventering av resistens mot antibakteriella medel hos enterokocker från kyckling (rapport). National Veterinary Institute, Uppsala. - ( A  , 1991. Resistensundersökning av svenska isolat av Treponema hyodysenteriae. 3VENSK 6ETERIN¤RTIDNING  349-352. 165-173. 229-32. -OLECULAR 'ENERAL 'ENETICS 341-348. 206-208. 441-447. 1413-1418. pp. 221-235. 62-70. 139. 1246-1248. p. 263. .ATURV¥RDSVERKET , 1996. Läkemedel och miljön. Rapport nr 4660. Naturvårdsverket, Stockholm. 1163-1166. 2125. 126. *OURNAL OF (YGIENE 217-231. 150. 510-513. 119-131. 567-72 issn: 0392-2990. 349-351.</p>
<h2>Annex F: Carbadox and olaquindox F.1 Introduction</h2>
<p>porcine proliferative enteritis). found.</p>
<h2>F.8 Toxicological aspects</h2>
<p>F.8.1 Target species</p>
<p>Carbadox</p>
<p>Olaquindox</p>
<p>Photoallergy</p>
<h2>F.9 Environmental effects F.10 Summary comments</h2>
<p>References 3UPPL  288-292. 397-407. 34-41. 85-95.</p>
<p>WHO, Geneva. 429-443. (OLMGREN .  , 1994. Profylaktiska effekter av zinkoxid eller olaquindox mot avvänjningsdiarré hos svin. 3VENSK 6ETERIN¤RTIDNING  217-222. 7IENER 4IER¤RZTLICHE -ONATSSCHRIFT 135-137. 2350. 203-209. 170. 6ETERINARY 2ECORD 367-370. 1349-1356.</p>
<p>July 3, Copenhagen. 375-392.</p>
<p>Copenhagen. p. 248.</p>
<p>Copenhagen. p. 249. 4OXICOLOGY IN 6ITRO 141-143. 0OULTRY 3CIENCE 2036-2042. 432-433, 436. 349-351.</p>
<p>Basic assumptions</p>
<p>Assumptions 1102 0 1.76 7 940 7 2.1% 1.3 7% 0.3 7% 0.1 1031 9 8.3% 5 1355 14</p>
<p>Assumptions</p>
<p>Assumptions</p>
